Six mid-cap stocks show rising quarterly EPS, but caution is advised as not all profitable companies are poised for long-term success.
Olympic champion Jess Fox undergoes successful surgery to remove kidney tumour, focuses on recovery and will miss upcoming World Cup events.
Lynas Rare Earths, a major non-Chinese producer, announces an $825 million capital raise to expand its operations and diversify the global rare earth supply chain.
Six mid-cap stocks show rising quarterly EPS, but caution is advised as not all profitable companies are poised for long-term success.
Olympic champion Jess Fox undergoes successful surgery to remove kidney tumour, focuses on recovery and will miss upcoming World Cup events.
Lynas Rare Earths, a major non-Chinese producer, announces an $825 million capital raise to expand its operations and diversify the global rare earth supply chain.